You will...
- Uncover how genetic insights guide the selection of personalized medicine.Â
- Explore the interaction between genetics, medication effectiveness, and patient well-being in the context of acne treatment.
- Walk away with the expertise to harness genetic data for tailored, effective acne treatments.
Your questions answered including:
- How does AcneTest™ transform genetic insights into personalized medicine selection for acne treatment?
- What steps will help providers become more comfortable with compounding medications, especially in terms of concentration and mechanism of action, as suggested by the AcneTest™ insights?
- How does AcneTest™ factor in the individual variations in response to therapies when suggesting treatments?
About the Speakers
Sarah Taylor, PharmD
Sarah attended undergrad at St. Olaf College in Northfield where she majored in chemistry and worked in a lab synthesizing dendrimers for possible use as pharmaceutical delivery molecules. It was there that she first developed an interest in pharmacy. She graduated from St. Olaf and pursued her interest in pharmacy at the University of Minnesota College of Pharmacy. During school, she began working at a compounding pharmacy utilizing her chemistry and pharmacy background to develop formulas for a myriad of pharmaceutical dosage forms and applications. After graduation, she continued to work at the compounding pharmacy for a total of 5 years. She uses this experience to help with her current position as Pharmacy Technical Consultant at Fagron.Â
Gustavo Torres, Ph.D.
Gustavo Torres, Project Manager at Fagron Genomics, specializes in molecular and human genetics, contributing to genetic test development and technical support. He earned his pharmacy degree from the Federal University of Juiz de Fora and conducted research on human adult stem cells in collaboration with USP and Butantan Institute. Dr. Torres was involved in establishing the first two institutional stem cell biorepositories and published research on adult stem cells as study models for genetic diseases, including neurofibromatosis type I. He also received an international research grant from the American Fund for the Improvement of Postsecondary Education (FIPSE) to study computational quantum chemistry at Colorado College during his pharmacy studies.